Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema (ACE)

This study is currently recruiting participants.
Verified March 2012 by Bernstein, Jonathan A., M.D.
Sponsor:
Collaborator:
Dyax Corp.
Information provided by:
Bernstein, Jonathan A., M.D.
ClinicalTrials.gov Identifier:
NCT01036659
First received: December 18, 2009
Last updated: March 8, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)